Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
2006 1
2011 1
2012 1
2013 2
2014 1
2017 2
2018 2
2019 1
2020 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children’s Oncology Group. Minard-Colin V, et al. N Engl J Med. 2020 Jun 4;382(23):2207-2219. doi: 10.1056/NEJMoa1915315. N Engl J Med. 2020. PMID: 32492302 Free PMC article. Clinical Trial.
RESULTS: Analyses were based on 328 patients who underwent randomization (164 patients per group); 85.7% of the patients had Burkitt's lymphoma. The median follow-up was 39.9 months. Events were observed in 10 patients in the rituximab-chemotherapy group and in 28 in the c …
RESULTS: Analyses were based on 328 patients who underwent randomization (164 patients per group); 85.7% of the patients had Burkitt's lymph …
Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma.
Ehrhardt MJ, Mulrooney DA, Li C, Baassiri MJ, Bjornard K, Sandlund JT, Brinkman TM, Huang IC, Srivastava DK, Ness KK, Robison LL, Hudson MM, Krull KR. Ehrhardt MJ, et al. Cancer. 2018 Jan 15;124(2):417-425. doi: 10.1002/cncr.31019. Epub 2017 Sep 15. Cancer. 2018. PMID: 28915338 Free PMC article.
Jude Lifetime Cohort who were 10 or more years from their diagnosis and were 18 years old or older underwent neurocognitive, emotional distress (Brief Symptom Inventory 18), and health-related quality of life (HRQOL) assessments (36-Item Short Form Health Survey). Age-adjusted z …
Jude Lifetime Cohort who were 10 or more years from their diagnosis and were 18 years old or older underwent neurocognitive, emotional distr …
Residential Exposure to PM(2.5) Components and Risk of Childhood Non-Hodgkin Lymphoma in Denmark: A Nationwide Register-Based Case-Control Study.
Hvidtfeldt UA, Erdmann F, Urhoj SK, Brandt J, Geels C, Ketzel M, Frohn LM, Christensen JH, Sørensen M, Raaschou-Nielsen O. Hvidtfeldt UA, et al. Int J Environ Res Public Health. 2020 Dec 1;17(23):8949. doi: 10.3390/ijerph17238949. Int J Environ Res Public Health. 2020. PMID: 33271946 Free PMC article.
In a recent study, we observed an increased risk of childhood non-Hodgkin lymphoma (NHL) associated with exposure to fine atmospheric particulate matter (PM(2.5)) and black carbon (BC). ...The estimates were attenuated after adjustment for PM(2. …
In a recent study, we observed an increased risk of childhood non-Hodgkin lymphoma (NHL) associated with …
Neurological complication of non Hodgkin lymphoma in childhood: experience from a single center in Turkey.
Kose D, Paksoy Y, Koksal Y, Unal E. Kose D, et al. Childs Nerv Syst. 2014 Apr;30(4):639-45. doi: 10.1007/s00381-013-2267-5. Epub 2013 Aug 30. Childs Nerv Syst. 2014. PMID: 23989474
In this study we aimed to review the neurological complications of childhood non Hodgkin Lymphoma (NHL). PATIENTS AND METHODS: Forty four children with NHL between 2006 and 2012 were investigated retrospectively and 14 cases with neurological complicat …
In this study we aimed to review the neurological complications of childhood non Hodgkin Lymphoma (NHL). PATIENT …
Burkitt Lymphoma/Leukaemia in Children & Young Adolescents.
O'Rourke E, Malone A, O'Marcaigh A, Storey L, Betts D, McDermott M, Smith OP. O'Rourke E, et al. Ir Med J. 2020 Jan 16;113(1):6. Ir Med J. 2020. PMID: 32298568
Aims Burkitt Lymphoma (BL) accounts for approximately 40% of childhood non-Hodgkin Lymphoma (NHL) in the developed world. Survival rates have improved dramatically in recent years, a success attributed to better use of poly-chemotherapy and targeted im …
Aims Burkitt Lymphoma (BL) accounts for approximately 40% of childhood non-Hodgkin Lymphoma (NHL) in the develop …
ATM alterations in childhood non-Hodgkin lymphoma.
Gumy-Pause F, Wacker P, Maillet P, Betts DR, Sappino AP. Gumy-Pause F, et al. Cancer Genet Cytogenet. 2006 Apr 15;166(2):101-11. doi: 10.1016/j.cancergencyto.2005.09.005. Cancer Genet Cytogenet. 2006. PMID: 16631465
The present study investigated the prevalence of ATM gene and ATM protein expression alterations in sporadic childhood non-Hodgkin lymphoma (NHL). Twenty-seven cases of NHL were screened for ATM mutations by denaturing high-performance liquid chromatog …
The present study investigated the prevalence of ATM gene and ATM protein expression alterations in sporadic childhood non- …
Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphoma.
van Waas M, Neggers SJ, Te Winkel ML, Beishuizen A, Pieters R, van den Heuvel-Eibrink MM. van Waas M, et al. Ann Oncol. 2012 Jun;23(6):1626-32. doi: 10.1093/annonc/mdr511. Epub 2011 Nov 2. Ann Oncol. 2012. PMID: 22048153 Free article.
BACKGROUND: Aim of this study was to investigate the long-term endocrine effects of treatment of childhood non-Hodgkin lymphoma (NHL). PATIENTS AND METHODS: A single-center cohort of 84 survivors (22 females) was included in this retrospective study. . …
BACKGROUND: Aim of this study was to investigate the long-term endocrine effects of treatment of childhood non-Hodgkin …
Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "Watch and wait" strategy after complete resection.
Attarbaschi A, Beishuizen A, Mann G, Rosolen A, Mori T, Uyttebroeck A, Niggli F, Csoka M, Krenova Z, Mellgren K, Kabickova E, Chiang AK, Reiter A, Williams D, Burkhardt B; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the international Berlin-Frankfurt-Münster (i-BFM) Study Group. Attarbaschi A, et al. Ann Hematol. 2013 Nov;92(11):1537-41. doi: 10.1007/s00277-013-1785-2. Epub 2013 May 12. Ann Hematol. 2013. PMID: 23665980
Conclusively, treatment outcome in pFL seems to be excellent with risk-adapted chemotherapy or after complete resection and an observational strategy only....
Conclusively, treatment outcome in pFL seems to be excellent with risk-adapted chemotherapy or after complete resection and an observatio …
Predictive ability of Lukes-Collins classification for immunologic phenotypes of childhood non-Hodgkin lymphoma: an institutional series and literature review.
Crist WM, Kelly DR, Ragab AH, Roper M, Dearth JC, Castleberry RP, Flint A. Crist WM, et al. Cancer. 1981 Nov 1;48(9):2070-5. doi: 10.1002/1097-0142(19811101)48:9<2070::aid-cncr2820480925>3.0.co;2-u. Cancer. 1981. PMID: 6975158
Most children were noted to have marked (B- or T-cell) neoplasms and the Lukes-Collins classification was predictive of immunologic phenotype in cases where markers were present. ...Frequently marrow and central nervous system involvement are observed in T-cell lymp …
Most children were noted to have marked (B- or T-cell) neoplasms and the Lukes-Collins classification was predictive of immunologic p …
Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection.
Ronceray L, Abla O, Barzilai-Birenboim S, Bomken S, Chiang AK, Jazbec J, Kabickova E, Lazic J, Beishuizen A, Mellgren K, Tanaka F, Pillon M, Devalck C, Gouttenoire M, Makarova O, Burkhardt B, Attarbaschi A; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group. Ronceray L, et al. Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26932. Epub 2017 Dec 29. Pediatr Blood Cancer. 2018. PMID: 29286565 Clinical Trial.
Thirty-three patients (50%) received a variable combination of adjuvant chemotherapy/immunotherapy/radiotherapy, while the remainder, including 20 of 21 with NMZL, entered an active observation period. Overall survival was excellent (98 2%), although 11 patients relapsed ( …
Thirty-three patients (50%) received a variable combination of adjuvant chemotherapy/immunotherapy/radiotherapy, while the remainder, includ …
13 results